{"id":755930,"date":"2023-05-08T09:15:08","date_gmt":"2023-05-08T13:15:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/"},"modified":"2023-05-08T09:15:08","modified_gmt":"2023-05-08T13:15:08","slug":"neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/","title":{"rendered":"Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR"},"content":{"rendered":"<h2>\nAchievement demonstrates Company\u2019s commitment to rigorous standards for safe and effective products<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">MALVERN, Pa., May  08, 2023  (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced its certification in two enhanced compliance programs. The Company has received CE Mark Certification for NeuroStar Advanced Therapy under the new Medical Device Regulation (MDR) in the European Union (EU) and the Medical Device Single Audit Program (MDSAP) certification.<\/p>\n<p>\u201cUnderscoring our commitment to rigorous regulatory and quality standards, our team has worked tirelessly to achieve these certifications from global regulatory agencies,\u201d said Keith J. Sullivan, President and CEO of Neuronetics. \u201cThese enhanced compliance standards lay the foundation for the company\u2019s future as a global organization with the potential to help patients worldwide.\u201d<\/p>\n<p>The EU MDR is a more stringent certification process that replaces the European Medical Device Directive. The process is designed to improve patient safety and ensure the effectiveness and quality of medical devices sold in the EU. It sets rigid requirements for developing, manufacturing, and marketing medical devices. The CE Mark is a symbol that indicates conformity with EU regulations, and it is a mandatory requirement for medical devices to be sold in the EU.<\/p>\n<p>MDSAP certification covers distribution in five countries, including the U.S., Japan, Canada, Australia, and Brazil. Once a company is registered in the country, MDSAP certification streamlines the audit process by allowing medical device manufacturers to undergo a single regulatory audit of their quality management system that fulfills the requirements of multiple regulatory jurisdictions.<\/p>\n<p>For more information about NeuroStar, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OmvlTfwVoepAvTIVw1hJLLueHd2FveviBm9Redc7y7TWDoyUORr3M-qWd2dVUmlvS808JJTIzPHZmkTEoxhOig==\" rel=\"nofollow noopener\" target=\"_blank\">neurostar.com<\/a>.<\/p>\n<p>\n        <strong>About<\/strong><br \/>\n        <strong>Neuronetics<\/strong><br \/>\n        <br \/>Neuronetics, Inc.\u00a0believes that mental health is as important as physical health. As a global leader in neuroscience,\u00a0Neuronetics\u00a0is redefining patient and physician expectations with its NeuroStar Advanced Therapy for Mental Health. NeuroStar is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions when traditional medication hasn\u2019t helped. NeuroStar is FDA-cleared for adults with major depressive disorder (MDD), as an adjunct for adults with obsessive-compulsive disorder (OCD), and to decrease anxiety symptoms in adult patients with MDD that may exhibit comorbid anxiety symptoms (anxious depression). NeuroStar Advanced Therapy is the leading transcranial magnetic stimulation (TMS) treatment for MDD in adults with over 5.3 million treatments delivered. NeuroStar is backed by the largest clinical data set of any TMS system for depression, including the world\u2019s largest depression Outcomes Registry.\u00a0Neuronetics\u00a0is committed to transforming lives by offering an exceptional treatment that produces extraordinary results. For safety and prescribing information,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PVzlzf39-ZQO6qwRo3RarHveqEpPOXN40Wr62jd3xc-FRfMl30z472wKTeuJgsxOPkDXJRG1LrpKApgyDTtnJgxC8qwlVlSpZK2-KjikEEAZBmo5p87-lmPNdze6RALAqP2GZqbH2aNzwqY5nCw_80kNUyuixofQsl29AvddfZ-hNMx-FVM0pU_1rlb6xHiNtE0WMyIW27sDb4uuxcHLkokTMQZUtuf5pB5yuNGz9oQ=\" rel=\"nofollow noopener\" target=\"_blank\"><strong>www.neurostar.com<\/strong><\/a>.<\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>EvolveMKD<br \/>646.517.4220<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=X_nsNWtKu7w2TWolYLi5xa3dY8DF7SPwU3jrsjG58N-QT15fGp4Y8EPHOYFoZBeMQJLQvxptmo1gE-X-pweapRD_8h9FD7bjsyhjrtjz7Kk=\" rel=\"nofollow noopener\" target=\"_blank\">NeuroStar@evolvemkd.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDMyNCM1NTcwMzU4IzIxMTA0NDA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjBkNWUyMTktY2E4MS00YjQ1LWI0OTAtNjExZjY3ZTQ2ZDU1LTExMjIwMTE=\/tiny\/Neuronetics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Achievement demonstrates Company\u2019s commitment to rigorous standards for safe and effective products MALVERN, Pa., May 08, 2023 (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced its certification in two enhanced compliance programs. The Company has received CE Mark Certification for NeuroStar Advanced Therapy under the new Medical Device Regulation (MDR) in the European Union (EU) and the Medical Device Single Audit Program (MDSAP) certification. \u201cUnderscoring our commitment to rigorous regulatory and quality standards, our team has worked tirelessly to achieve these certifications from global regulatory agencies,\u201d said Keith J. Sullivan, President and CEO of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-755930","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Achievement demonstrates Company\u2019s commitment to rigorous standards for safe and effective products MALVERN, Pa., May 08, 2023 (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced its certification in two enhanced compliance programs. The Company has received CE Mark Certification for NeuroStar Advanced Therapy under the new Medical Device Regulation (MDR) in the European Union (EU) and the Medical Device Single Audit Program (MDSAP) certification. \u201cUnderscoring our commitment to rigorous regulatory and quality standards, our team has worked tirelessly to achieve these certifications from global regulatory agencies,\u201d said Keith J. Sullivan, President and CEO of &hellip; Continue reading &quot;Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-08T13:15:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDMyNCM1NTcwMzU4IzIxMTA0NDA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR\",\"datePublished\":\"2023-05-08T13:15:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\\\/\"},\"wordCount\":461,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDMyNCM1NTcwMzU4IzIxMTA0NDA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\\\/\",\"name\":\"Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDMyNCM1NTcwMzU4IzIxMTA0NDA=\",\"datePublished\":\"2023-05-08T13:15:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDMyNCM1NTcwMzU4IzIxMTA0NDA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDMyNCM1NTcwMzU4IzIxMTA0NDA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/","og_locale":"en_US","og_type":"article","og_title":"Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR - Market Newsdesk","og_description":"Achievement demonstrates Company\u2019s commitment to rigorous standards for safe and effective products MALVERN, Pa., May 08, 2023 (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced its certification in two enhanced compliance programs. The Company has received CE Mark Certification for NeuroStar Advanced Therapy under the new Medical Device Regulation (MDR) in the European Union (EU) and the Medical Device Single Audit Program (MDSAP) certification. \u201cUnderscoring our commitment to rigorous regulatory and quality standards, our team has worked tirelessly to achieve these certifications from global regulatory agencies,\u201d said Keith J. Sullivan, President and CEO of &hellip; Continue reading \"Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-08T13:15:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDMyNCM1NTcwMzU4IzIxMTA0NDA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR","datePublished":"2023-05-08T13:15:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/"},"wordCount":461,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDMyNCM1NTcwMzU4IzIxMTA0NDA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/","name":"Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDMyNCM1NTcwMzU4IzIxMTA0NDA=","datePublished":"2023-05-08T13:15:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDMyNCM1NTcwMzU4IzIxMTA0NDA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDMyNCM1NTcwMzU4IzIxMTA0NDA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-receives-mdsap-certification-and-ce-mark-certification-under-new-mdr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/755930","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=755930"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/755930\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=755930"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=755930"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=755930"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}